C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2004
11/10/2004	CN1544471A Bovine mastitis resistant yolk antibody and its preparation method and formulation
11/10/2004	CN1544467A Variable region gene of high neutralization activity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544466A Variable region gene of high affinity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544462A Heterologous expression of neisserial proteins
11/10/2004	CN1175113C Method for increasing yield of recombinant proteins in microbial fermentation processes
11/10/2004	CN1175110C Amidated recombinant polypeptide and its preparation
11/10/2004	CN1174774C Chinese medicine multienzyme emulsifying method
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815194 Cytidine deaminase
11/09/2004	US6815184 Generating preferential polypeptide in plant; obtain plant cells, transform with vector containing preferential polypeptide, express vector, recover polypeptide
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004	US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	CA2343358C Cerebral organic anion transporter and its gene
11/09/2004	CA2304437C Process for the production of naturally folded and secreted proteins
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA2035381C Preparation and use of gene banks of human antibodies ("human-antibody libraries")
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094790A2 Extendable/retractable support column
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094633A1 Process for producing recombinant protein in bacterium belonging to the genus rhodococcus
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094608A2 Human procolipase like nucleic acids and polypeptides and their methods of use threof
11/04/2004	WO2004094593A2 Expanding the eukaryotic genetic code
11/04/2004	WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004	WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
11/04/2004	WO2004084808A3 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004050847A3 Modified antibodies stably produced in milk and methods of producing same
11/04/2004	WO2004033706A3 Nucleic acids encoding duramycin
11/04/2004	WO2004033705A3 Viral interferon antagonists and uses therefor
11/04/2004	WO2004027043A3 Method for production of a multimeric protein by cell fusion
11/04/2004	WO2004009618A3 Recombinant production of mixtures of antibodies
11/04/2004	WO2004002417A3 Mammalian ch1 deleted mimetibodies, compositions, methods and uses
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2003102200A3 Fermentation process using specific oxygen uptake rates as a process control
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003076473A8 Specific ab1'-antibodies against tumour-associated antigen ca 125
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003046573A3 Protein biopolymer markers predictive of insulin resistance
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	US20040221334 Immunoglobulin for use in detection of modified insecticidal protein; immunodiagnostics and heterologous gene expression; tissue engineering and biological pest control
11/04/2004	US20040221327 Antibodies against autoantigens of primary billary cirrhosis and methods of making and using them
11/04/2004	US20040220130 Compact synthetic expression vector comprising double-stranded DNA molecules and methods of use thereof
11/04/2004	US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004	US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004	US20040219667 Monoclonal antibody for human telomerase catalytic subunit
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219643 Dual-specific ligand
11/04/2004	US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004	US20040219641 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004	US20040219633 Method of producing recombinant antibodies
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	US20040219631 Method for producing tripeptides and/or peptides longer than tripeptides
11/04/2004	US20040219630 Production of functional polypeptides originating from silk protein and use thereof
11/04/2004	US20040219621 Test methods and devices
11/04/2004	US20040219614 Produced from a hybridoma prepared by fusing a mouse spleen and myeloma cell; detecting tumors; kits
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219553 Alpha-1,2-fucosyltransferase and dna encoding the same
11/04/2004	US20040219516 Expression vector comprising multiple recombination and/or topoisomerase sites for use as gene transfer tool in ptokaryotic and eukaryotic cells
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219163 Cell of vector that encodes the antigen
11/04/2004	US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004	DE10315376A1 Culturing Rhodococcus rhodochrous for preparation of nitrile hydratase, useful for converting nitriles to amides, particularly preparation of acrylamide, by growing in phosphate-buffered medium of pH 5.5 to 9
11/04/2004	CA2528503A1 Tolerance to graft prior to thymic regeneration
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2520750A1 Orthogonal aminoacyl-trna synthetase
11/04/2004	CA2517134A1 Methods for obtaining colonization factors from bacterial strains
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472373A2 Methods for making polynucleotides and purifying double-stranded polynucleotides
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472352A2 Novel compounds
11/03/2004	EP1472342A2 Oxa1p enhanced protein secretion
11/03/2004	EP1472289A1 Stabilization of protein preparations
11/03/2004	EP1472286A1 Production process of recombinant placental growth factor
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471937A1 A continuous cell line for the production of vaccines
11/03/2004	EP1471936A2 Hiv vaccine and method of use
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1434871A4 Selection of cells expressing heteromeric polypeptides
11/03/2004	EP1228087A4 Antibody catalysis of enantio- and diastereo-selective aldol reactions
11/03/2004	EP0821794B1 Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays
11/03/2004	EP0705338B1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)

1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 1125